Synthesis and biological evaluation of some potential antimalarials

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Malaria chemotherapy faces significant challenges due to increasing parasite resistance to established drugs such as chloroquine and amodiaquine.
• Limited availability of new antimalarial drugs exacerbates the problem, necessitating the development of novel therapeutic agents.

Purpose of the Study:

• To synthesize a novel quinoline derivative, 2-tribromomethyl-6-methoxy-4-(4-hydroxy-3-pyrrolidinomethylanilino)quinoline (1), as a potential biocide.
• To address the issue of drug resistance in malaria by developing a compound that may circumvent common resistance mechanisms.

Main Methods:

• Synthesis of the target compound (1) based on structural modifications suggested by Pinder and Burger.
• The proposed modification involves introducing a trifluoromethyl group to prevent oxidation at the C-2 position of cinchona alkaloids' metabolites, which is linked to loss of activity.

Main Results:

• Successful synthesis of the novel quinoline derivative (1).
• The structural modification aims to prevent metabolic oxidation, potentially preserving or enhancing antimalarial activity.
• The compound is proposed as a potential biocide for malaria treatment.

Conclusions:

• The synthesized quinoline derivative (1) represents a promising candidate for further investigation as an antimalarial drug.
• Structural modification of existing antimalarial scaffolds can be a viable strategy to overcome drug resistance.
• Further studies are warranted to evaluate the efficacy and safety of compound (1) against malaria parasites.